Press Release: Cadence Pharmaceuticals : SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. in Connection With the Sale of the Company to Mallinckrodt plc

BALA CYNWYD, Pa.--(BUSINESS WIRE)--Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cadence Pharmaceuticals, Inc. (“Cadence” or the “Company”) (Nasdaq: CADX) relating to the acquisition by Mallinckrodt plc (“MNK”). Click here to learn more about the investigation http://brodsky-smith.com/721-cadx-cadence-pharmaceuticals-inc-.html, or call: 877-534-2590. There is no cost or obligation to you. Cadence announced that the t